Risk factors for severe radiation pneumonitis in lung cancer

Japanese Journal of Clinical Oncology

Volumn 29, Issue 4, 1999, Pages 192-197

  Makimoto, Takeyuki ^a,c   Tsuchiya, Satoshi ^a   Hayakawa, Kazushige ^b   Saitoh, Ryusei ^a   Mori, Masatomo ^b  

^a Shibukawa Medical Center   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c MAEBASHI RED CROSS HOSPITAL   (Japan)

Author keywords

Interstitial change; Primary lung cancer; Radiation pneumonitis; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; LUNG TUMOR; MALE; MEGAVOLTAGE RADIOTHERAPY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; RADIATION PNEUMONIA; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RADIATION PNEUMONITIS; RADIOTHERAPY, HIGH-ENERGY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033113237     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.4.192     Document Type: Article

References (42)

1. Chevalier TL, Arriagada R, Quoix E, Ruffie P, Martin M, Tarayre M, et al. Radiation alone vs combined chemotherapy and radiotherapy in nonresectable nonsmall-cell lung cancer: First analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991;83:417-23.
2. Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, et al. A randomized trial of induction chemotherapy plus high-dose radiation vs radiation alone in stage II non-small-cell lung cancer. N Engl J Med 1990;323:940-5.
3. Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer. J Natl Cancer Inst 1995;87:198-205.
4. Gross NJ. Pulmonary effects of radiation therapy. Ann Intern Med 1977;86:81-92.
5. Roswit B, White DC. Severe radiation injury of the lung. Am J Roentgenol 1977;129:127-36.
6. Fleming JA, Filbee JF, Wiernik G. Sequelae to radical irradiation in carcinoma of the breast. Br J Radiol 1961;34:713-9.
7. Shapiro SJ, Shapiro SD, Mill WB, Campbell EJ. Prospective study of long-term pulmonary manifestations of mantle irradiation. Int J Radiat Oncol Biol Phys 1990;19:707-14.
8. Gibson PG, Bryant DH, Morgan GW. Radiation-induced lung injury: a hypersensitivity pneumonitis? Ann Intern Med 1988;109:288-91.
9. Goldman AL, Enquist R. Hyperactive radiation pneumonitis. Chest 1975;67:613-5.
10. Saunas FV, Winterbauer RH. Radiation pneumonitis: a mimic of infectious pneumonitis. Semin Respir Infect 1995;10:143-53.
11. Cohen Y, Gellei B, Robinson E. Bilateral radiation pneumonitis after unilateral lung and mediastinal irradiation. Radiol Clin North Am 1974;43:465-71.
12. Byhardt RW, Abrams R, Almagro U. The associations of adult respiratory distress syndrome (ARDS) with thoracic irradiation (RT). Int J Radiat Oncol Biol Phys 1988;15:1441-6.
13. Bennett DE, Million RR, Ackerman LV. Bilateral radiation pneumonitis, a complication of the radiotherapy of bronchogenic carcinoma (report and analysis of seven cases with autopsy). Cancer 1969;23:1001-18.
14. Fulkerson WJ, McLendon RE, Prosnitz LR. Adult respiratory distress syndrome after limited thoracic radiotherapy. Cancer 1986;57:1941-6.
15. Japanese Lung Cancer Society. General Rules for Clinical and Pathologic Record of Lung Cancer, 3rd ed. Tokyo: Kanehara Shuppan 1987;15-21.
16. Madrazo A, Suzuki Y, Churg J. Radiation pneumonitis: ultrastractural changes in the pulmonary alveoli following high doses of radiation. Arch Pathol 1973;96:262-8.
17. Roberts CM, Foulcher E, Zaunder JJ, Bryant DH, Freund J, Cairns D, et al. Radiation pneumonitis: a possible lymphocyte-mediated hypersensitivity reaction. Ann Intern Med 1993;118:696-70.
18. Morgan GW, Pharm B, Breit SN. Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys 1995;31:361-9.
19. Nakayama Y, Makino S, Fukuda Y, Min K, Shimizu A, Ohsawa N. Activation of lavage lymphocytes in lung injuries caused by radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 1996;34:459-67.
20. Wechsler RJ. Ayyangar K, Steiner RM, Yelovich R, Moylan DM. The development of distant pulmonary infiltrates following thoracic irradiation: the role of computed tomography with dosimetric reconstruction in diagnosis. Comput Med Imag Graph 1990;14:43-51.
21. Kataoka M. Gallium-67 citrate imaging for the assessment of radiation pneumonitis. Ann Nucl Med 1989;3:73-81.
22. Phillips TL, Wharam MD, Margolis LW. Modification of radiation injury to normal tissues by chemotherapeutic agents. Cancer 1975;35:1678-84.
23. Samuels ML, Douglas EJ, Holoye PV, Lanzotti VJ. Large dose bleomycin therapy and pulmonary toxicity. J Am Med Assoc 1976;235:1117-20.
24. Lehne G, Lote K. Pulmonary toxicity of cytotoxic and immunosuppressive agents. A review. Acta Oncol 1990;29:113-24.
25. Gunstream SR, Seidenfeld JJ, Sobonya RE, McMahon LJ. Mitomycin associated lung disease. Cancer Treat Rep 1983;67:301-4.
26. Verschoore J, Lagrange JL, Boublil JL, Aubanel JM, Blaive B, Pinto J, et al. Pulmonary toxicity of a combination of low-dose doxorubicin and irradiation for inoperable lung cancer. Radiother Oncol 1987;9:281-8.
27. Segawa Y, Takigawa N, Kataoka M, Tanaka I, Fujimoto N, Ueoka H. Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer. Int J Radiat Oncol Biol Phys 1997;39:91-9.
28. Phillips TL. Radiation fibrosis. In: Fishman AP, editor. Pulmonary Diseases and Disorders, vol 1. New York:McGraw-Hill 1988;773-92.
29. Monson JM, Stark P, Reilly JJ, Sugarbaker GM, Swanson SJ, Decamp MM, et al. Clinical radiation peumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer 1998;82:842-50.
30. Bennett DE, Million RR, Ackerrman LV. Bilateral radiation pneumonitis, a complication of the radiotherapy of bronchogenic carcinoma. (report and analysis of seven cases with autopsy). Cancer 1969;23:1001-18.
31. Smith JC. Radiation pneumonitis: a review. Am Rev Respir Dis 1963;87: 647-55.
32. Shulimuzon T, Apter S, Weitzen R, Yellin A, Brenner HJ, Wollner A. Radiation pneumonitis complicating mediastinal radiotherapy postneumonectomy. Eur Resp J 1996;9:2697-9.
33. DeRemee RA. Serum lactic dehydrogenase activity and diffuse interstitial pneumonitis. J Am Med Assoc 1968;204:1193-5.
34. Kohno N, Hamada H, Fujioka S, Hiwada K, Yamakido M, Akiyama M. Circulating antigen KL-6 and lactic dehydrogenase for monitoring irradiated patients with lung cancer. Chest 1992;102:117-22.
35. Kirk JME, Bateman ED, Haslam, PL, Laurent GJ, Turner WM. Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevance. Thorax 1984;39:726-32.
36. Anscher MS, Murase T, Prescott DM, Marks LB, Reisenbichler H, Benter GC, et al. Changes in plasma TGF-β levels during pulmonary radiotherapy as a predicter of the risk of developing radiation pneumonitis. Int J Radiat Oncol Biol Phys 1994;30:671-6.
37. Anscher MS, Kong FM, Marks LB, Bentel GC, Jirtle RL. Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys 1997;37:253-8.
38. Castellino RA, Gratstein E, Turbow MM, Rosenberg S, Kaplan HS. Latent radiation injury of lung or heart activated by steroid withdrawal. Ann Intern Med 1974;80:593-9.
39. Pezner RD, Bertrand M, Cecchi GR, Paladugu RR, Kendregan BA. Steroid-withdrawal radiation pneumonitis in cancer patients. Chest 1984; 85:816-7.
40. Ward HE, Kemsley L, Davies L, Holecek M, Berend N. The effect of steroids on radiation-induced lung disease in the rat. RadiatRes 1993;136:22-8.
41. McCarty MJ, Lillis P, Vukelja SJ. Azathioprine as a steroid-sparing agent in radiation pneumonitis. Chest 1996;109:1397-1400.
42. Rosiello RA, Merrill WW, Rockwell S, Carter D, Cooper JAD Jr, Care S, Amento EP. Radiation pneumonitis: bronchoalveolar lavage assessment and modulation by a recombinant cytokine. Am Rev Respir Dis 1993;148:1671-6.